Literature DB >> 22197448

Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease.

Lyn M Wancket1, W Joshua Frazier, Yusen Liu.   

Abstract

Mitogen-activated protein kinases (MAPKs) are key regulators of cellular physiology and immune responses, and abnormalities in MAPKs are implicated in many diseases. MAPKs are activated by MAPK kinases through phosphorylation of the threonine and tyrosine residues in the conserved Thr-Xaa-Tyr domain, where Xaa represents amino acid residues characteristic of distinct MAPK subfamilies. Since MAPKs play a crucial role in a variety of cellular processes, a delicate regulatory network has evolved to control their activities. Over the past two decades, a group of dual specificity MAPK phosphatases (MKPs) has been identified that deactivates MAPKs. Since MAPKs can enhance MKP activities, MKPs are considered as an important feedback control mechanism that limits the MAPK cascades. This review outlines the role of MKP-1, a prototypical MKP family member, in physiology and disease. We will first discuss the basic biochemistry and regulation of MKP-1. Next, we will present the current consensus on the immunological and physiological functions of MKP-1 in infectious, inflammatory, metabolic, and nervous system diseases as revealed by studies using animal models. We will also discuss the emerging evidence implicating MKP-1 in human disorders. Finally, we will conclude with a discussion of the potential for pharmacomodulation of MKP-1 expression.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22197448      PMCID: PMC3465723          DOI: 10.1016/j.lfs.2011.11.017

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  169 in total

1.  Protection from septic shock by neutralization of macrophage migration inhibitory factor.

Authors:  T Calandra; B Echtenacher; D L Roy; J Pugin; C N Metz; L Hültner; D Heumann; D Männel; R Bucala; M P Glauser
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

2.  NF-kappaB-mediated expression of MAPK phosphatase-1 is an early step in desensitization to TLR ligands in enterocytes.

Authors:  J Wang; H R Ford; A V Grishin
Journal:  Mucosal Immunol       Date:  2010-06-16       Impact factor: 7.313

Review 3.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

4.  JNK1 Is required for the induction of Mkp1 expression in macrophages during proliferation and lipopolysaccharide-dependent activation.

Authors:  Ester Sánchez-Tilló; Mónica Comalada; Jordi Xaus; Consol Farrera; Annabel F Valledor; Carme Caelles; Jorge Lloberas; Antonio Celada
Journal:  J Biol Chem       Date:  2007-03-02       Impact factor: 5.157

5.  Selective prostacyclin receptor agonism augments glucocorticoid-induced gene expression in human bronchial epithelial cells.

Authors:  Sylvia M Wilson; Pamela Shen; Christopher F Rider; Suzanne L Traves; David Proud; Robert Newton; Mark A Giembycz
Journal:  J Immunol       Date:  2009-10-30       Impact factor: 5.422

6.  The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts.

Authors:  D R Alessi; C Smythe; S M Keyse
Journal:  Oncogene       Date:  1993-07       Impact factor: 9.867

Review 7.  Dual-specificity MAP kinase phosphatases (MKPs) and cancer.

Authors:  Stephen M Keyse
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

Review 8.  Regulation of innate immune response by MAP kinase phosphatase-1.

Authors:  Xianxi Wang; Yusen Liu
Journal:  Cell Signal       Date:  2007-04-20       Impact factor: 4.315

9.  MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.

Authors:  S Chattopadhyay; R Machado-Pinilla; C Manguan-García; C Belda-Iniesta; C Moratilla; P Cejas; J A Fresno-Vara; J de Castro-Carpeño; E Casado; M Nistal; M Gonzalez-Barón; R Perona
Journal:  Oncogene       Date:  2006-02-06       Impact factor: 9.867

10.  Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors.

Authors:  M A Collart; D Belin; J D Vassalli; S de Kossodo; P Vassalli
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more
  45 in total

1.  Compound 9a, a novel synthetic histone deacetylase inhibitor, protects against septic injury in mice by suppressing MAPK signalling.

Authors:  So-Jin Kim; Ki Seon Baek; Hyun-Ju Park; Young Hoon Jung; Sun-Mee Lee
Journal:  Br J Pharmacol       Date:  2016-02-22       Impact factor: 8.739

2.  Circulating cortisol-associated signature of glucocorticoid-related gene expression in subcutaneous fat of obese subjects.

Authors:  Maria G Pavlatou; Kasey C Vickers; Sudhir Varma; Rana Malek; Maureen Sampson; Alan T Remaley; Philip W Gold; Monica C Skarulis; Tomoshige Kino
Journal:  Obesity (Silver Spring)       Date:  2013-05       Impact factor: 5.002

3.  Cross regulation of signaling pathways in gastrointestinal stromal tumor.

Authors:  Yijun Qi; Wendi Zhao; Zhengguang Wang; Qingsong Xie; Jing Cao; Xiangling Meng
Journal:  Oncol Lett       Date:  2018-09-24       Impact factor: 2.967

Review 4.  Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 in Nervous System Development and Disease.

Authors:  Louise M Collins; Eric J Downer; André Toulouse; Yvonne M Nolan
Journal:  Mol Neurobiol       Date:  2014-06-24       Impact factor: 5.590

5.  Azelastine enhances the clinical efficacy of glucocorticoid by modulating MKP-1 expression in allergic rhinitis.

Authors:  Xi Luo; Renqiang Ma; Xingmei Wu; Desheng Xian; Jian Li; Zhonglin Mou; Huabin Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-25       Impact factor: 2.503

6.  Regulation of mitogen-activated protein kinase by protein kinase C and mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle.

Authors:  Danielle M Trappanese; Sarah Sivilich; Hillevi K Ets; Farah Kako; Michael V Autieri; Robert S Moreland
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-06       Impact factor: 4.249

7.  Suppression of cytokine production by glucocorticoids is mediated by MKP-1 in human lung epithelial cells.

Authors:  Tiina Keränen; Eeva Moilanen; Riku Korhonen
Journal:  Inflamm Res       Date:  2017-03-15       Impact factor: 4.575

Review 8.  The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.

Authors:  Ahmed Shah; Raed Alhusayen; Saeid Amini-Nik
Journal:  Inflamm Res       Date:  2017-06-27       Impact factor: 4.575

9.  Mitogen-activated protein kinase phosphatase (MKP)-1 as a neuroprotective agent: promotion of the morphological development of midbrain dopaminergic neurons.

Authors:  Louise M Collins; Gerard W O'Keeffe; Caitriona M Long-Smith; Sean L Wyatt; Aideen M Sullivan; André Toulouse; Yvonne M Nolan
Journal:  Neuromolecular Med       Date:  2013-04-13       Impact factor: 3.843

10.  Role of MKP-1 (DUSP1) in clozapine-induced effects on the ERK1/2 signaling pathway in the rat frontal cortex.

Authors:  Se Hyun Kim; Hyun Sook Yu; Hong Geun Park; Soyoung Park; Myoung Suk Seo; Won Je Jeon; Yong Min Ahn; Kyooseob Ha; Soon Young Shin; Yong Sik Kim
Journal:  Psychopharmacology (Berl)       Date:  2013-06-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.